The Mankind Pharma IPO has begun on 25-Apr-2023. It will close on 27-Apr-2023. The Total IPO Size is 4,326.36 Crore. The company set its IPO price is 1026-1080 Rs Per Share. Basically, there are three basic categories in Mankind Pharma IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Retail Individual Investors (RIIs).
Mankind Pharma is Majorly know for it’s Product “Manforce condoms”. Mankind Pharma is a India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022.
They are engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
The 97.60% total revenue comes from the Domestic market. They have created 36 brands in thier pharmaceutical business that have each achieved over ₹500.00 million in FY22.
They have several differentiated brands in the condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories.
| Latest News Update: Mankind Pharma IPO Subscription Status Live | |
|
Mankind Pharma IPO Subscription Status
| Day 1 (times) | Day 2 (times) | Day 3 (times) | |
| QIB | 0.08 | 1.86 | 49.16 |
| NII | 0.33 | 1.02 | 3.80 |
| Retail | 0.10 | 0.25 | 0.92 |
| Total | 0.14 | 0.88 | 15.32 |
